No abstract available
MeSH terms
-
Case Management*
-
Cerebral Hemorrhage / chemically induced
-
Cerebral Hemorrhage / mortality
-
Drug Evaluation
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Health Services Accessibility
-
Hospital Mortality
-
Hospitals, Community
-
Hospitals, Special
-
Humans
-
Multicenter Studies as Topic
-
Patient Education as Topic
-
Risk
-
Safety
-
Stroke / drug therapy*
-
Stroke / mortality
-
Thrombolytic Therapy* / adverse effects
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / adverse effects
-
Tissue Plasminogen Activator / therapeutic use*
-
Treatment Outcome
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator